Abstract
Testosterone (T) and dehydroepiandrosterone (DHEA) are fat-reducing hormones, even though they exert this effect by different mechanisms. In particular, T inhibits lipid uptake and lipoprotein-lipase (LDL) activity in adipocytes, and stimulates lipolysis by increasing the number of lipolytic β-adrenergic receptors. An indirect sign of these effects is the decrease of adipocyte leptin production. Lastly, T inhibits differentiation of adipocyte precursor cells. Concerning DHEA, this hormone does not seen to have any of T effects; however, DHEA stimulates resting metabolic rate (RMR) and lipid oxidation, and enhances glucose disposal, by increasing the expression of GLUT-1 and GLUT-4 on fat cell plasma membrane. The insulin-like effect of DHEA would be associated to a decrease of plasma insulin concentrations and, thus, to an increase of the molar ratio between lipolytic hormones and insulin. Noteworthy, the fat-reducing effect of both T and DHEA seems to be more evident at the level of visceral adipose tissue.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Pergola, G. The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone. Int J Obes 24 (Suppl 2), S59–S63 (2000). https://doi.org/10.1038/sj.ijo.0801280
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801280
Keywords
This article is cited by
-
Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes
Journal of Ovarian Research (2023)
-
Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
British Journal of Cancer (2023)
-
Male sex hormones, aging, and inflammation
Biogerontology (2023)
-
Metabolomics of testosterone enanthate administration during severe-energy deficit
Metabolomics (2022)
-
Endocrine system dysfunction and chronic heart failure: a clinical perspective
Endocrine (2022)